Home/Uvax Bio/Ke Li, PhD., MBA
KL

Ke Li, PhD., MBA

CMC Consultant

Uvax Bio

Therapeutic Areas

Uvax Bio Pipeline

DrugIndicationPhase
HIV-1 VaccineHIV-1 preventionPre-clinical
Undisclosed Asset 1Infectious DiseaseResearch
Undisclosed Asset 2Infectious DiseaseResearch
Undisclosed Asset 3Infectious DiseaseResearch